NCT06086093View on ClinicalTrials.gov

Evaluate the Efficacy of RespireAidTM in Patient With Externally Contracted Seasonal Epidemic (外感時疫)

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

August 7, 2023

Primary Completion Date

October 11, 2023

Study Completion Date

December 15, 2023

Conditions
Respiration Disorders
Interventions
DIETARY_SUPPLEMENT

RespireAid TM/placebo

"Direction: Take 1 sachet(5g) 4 times daily~Indication: Externally contracted seasonal epidemic~Function: Relieving Exterior and Facilitating Lung, clear heat of lung, Wide chest and resolve phlegm"

Trial Locations (2)

807

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Unknown

Linkou Chang-Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Sun Ten Pharmaceutical Co., Ltd.

INDUSTRY